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ABSTRACT: The QacR multidrug-binding repressor protein regulates the expression of the Staphylococcus
aureus qacA gene, a multidrug resistance (MDR) locus that is prevalent in clinical isolates of this important
human pathogen. In this paper we demonstrate that the range of structurally diverse compounds capable
of inducing qacA transcription is significantly more varied than previously appreciated, particularly in
relation to bivalent cations. For all of the newly identified inducing compounds, induction of qacA
expression was correlated with a matching ability to dissociate QacR from operator DNA. Development
of a ligand-binding assay based on intrinsic tryptophan fluorescence permitted dissociation constants to
be determined for the majority of known QacR ligands, with values ranging from 0.2 to 82 íM. High-
affinity binding of a compound to QacR in vitro was not found to correlate very strongly with either its
in vivo inducing abilities or its structure. The latter observation indicated that the QacR ligand-binding
pocket appears to have evolved to accommodate a wide range of toxic hydrophobic cations, rather than
a specific class of compound. Importantly, the antimicrobial ligands of QacR included several plant alkaloids
that share structural similarities with synthetic MDR substrates. This is consistent with the suggestion
that the qacA-qacR MDR locus was recently derived from genes that protect against natural antimicrobial
compounds.
Multidrug resistance (MDR)1 transport proteins possessed
by infectious microorganisms have emerged as a significant
medical threat due to their impressive substrate ranges, which
can include many antibiotics, antifungal agents, disinfectants,
and antiseptics (1-3). Additionally, overexpression of the
human MDR transporter, P-glycoprotein, in tumor cells can
provide resistance to chemotherapeutic compounds (4).
Although MDR transporters share the common property of
mediating the export of structurally diverse toxic substrates,
a large body of evidence suggests that for the majority of
such pumps this function is not their intended physiological
role, which is particularly apparent when it is taken into
consideration that the majority of known MDR transporter
substrates are synthetic compounds (1).
To assist efforts aimed at overcoming the health threats
posed by the existence of MDR transporters, a number of
important questions need to be addressed in relation to their
function, such as determining the basis for their broad
substrate range and the physiological functions of these
proteins. The recently determined crystal structure of the
MDR transport protein AcrB complexed to four different
substrates has provided us with clues as to the mechanism
employed by these proteins to recognize a range of com-
pounds (5). Additionally, significant progress toward under-
standing the structural basis for multidrug recognition has
been achieved via the analysis of soluble multidrug-sensing
bacterial regulatory proteins, which mediate the expression
of MDR genes via mechanisms that involve binding to a
similar range of compounds as their cognate transporters (6,
7). The publication of high-resolution structural data for the
Staphylococcus aureus QacR repressor bound to each of six
structurally diverse ligands (8) has provided us with a
comprehensive view of the architecture of a multidrug-
binding pocket, building upon earlier work which generated
a structure for the Bacillus subtilis BmrR multidrug-binding
regulator bound to a single ligand (9). The basis of multidrug
binding revealed by these combined structures is the avail-
ability of a range of amino acid side chains lining the binding
pocket that provide possibilities for the formation of alterna-
tive complementary electrostatic, aromatic stacking, and
hydrophobic interactions with each ligand, assisted by
opportunities for hydrogen bond formation.
Attempts to answer the second of the above questions has
led to the identification of natural substrates for several MDR
transporters (7, 10-14). Although this represents an impor-
tant first step, it must also be established whether the
regulatory mechanisms governing the expression of the
exporter in question mediate increased transporter production
in response to the presence of these “physiological” sub-
strates. Thus, the analysis of bacterial multidrug-sensing
regulatory proteins can also help to determine whether the
export of a natural compound represents a primary physi-
ological role of a drug pump. However, the provision of
† This work was supported in part by Project Grants 153817 and
153818 from the National Health and Medical Research Council
(Australia) to R.A.S. and M.H.B.
* To whom correspondence should be addressed. Tel: 61-2-9351-
2376. Fax: 61-2-9351-4771. E-mail: skurray@bio.usyd.edu.au.
‡ Present address: INSERM U412, Ecole Normale Supe´rieure de
Lyon, 46 alle´e d’Italie, 69364 Lyon Cedex 07, France.
1 Abbreviations: MDR, multidrug resistance; PqacA, qacA promoter;
DAPI, 4′,6-diamidino-2-phenylindole; DiOC3, 3′,3′-dipropyloxacar-
bocyanine; CAT, chloramphenicol acetyltransferase; Qac, quaternary
ammonium compound.
15226 Biochemistry 2003, 42, 15226-15236
10.1021/bi035447+ CCC: $25.00 © 2003 American Chemical Society
Published on Web 12/03/2003
examples where a natural MDR pump substrate has also been
documented to cause induction of expression via a well-
characterized mechanism has been difficult to obtain. For
example, despite spermidine representing the only natural
substrate identified to date for the B. subtilis Blt MDR
transporter (14), spermidine and related polyamines are not
bound by the BltR local regulatory protein; in fact, these
compounds fail to cause induction of blt expression by any
mechanism (15). However, a more promising example is
provided by the S. aureus qacA-qacR locus, for which the
plant alkaloid berberine has been shown to be a substrate of
the QacA MDR pump (12), in addition to the QacR
regulatory protein possessing a demonstrated ability to bind
berberine in vitro (8).
The QacR protein is a TetR family member that negatively
regulates transcription of the divergently encoded QacA
MDR pump by binding as a pair of dimers to the IR1
operator sequence, a large inverted repeat immediately
upstream of the qacA promoter (PqacA) (16, 17). The structural
basis for the conformational changes that occur within QacR
upon binding QacA substrates, thereby resulting in QacR
adopting a non-DNA-binding configuration and the con-
comitant derepression of PqacA, has been recently elucidated
(18). The qacA-qacR locus, which confers antiseptic and
disinfectant resistance, is prevalent on multiresistance plas-
mids that are frequently isolated from clinical strains of S.
aureus (19-21). The QacA integral membrane pump exports
a wide range of toxic monovalent and bivalent lipophilic
substrates, which includes more than 30 distinct compounds
(22-24). Although fluorescent assays have been used to
determine the kinetic parameters of transport, viz., the Km
and Vmax values for QacA-mediated export of four fluorescent
substrates, 4′,6-diamidino-2-phenylindole (DAPI), 3′,3′-
dipropyloxacarbocyanine (DiOC3), ethidium, and pyronin Y
(22), relatively little is known about the range of compounds
bound by the QacR regulatory protein and almost nothing
regarding the relative affinity of QacR for various ligands.
Furthermore, although a crystal structure exists for QacR
bound to the plant alkaloid berberine (8), no data have been
published on the ability of berberine to cause induction of
qacA expression in vivo or on the in vitro binding affinity
of QacR for this compound. In fact, the only published
binding affinity determined to date has been that for
rhodamine 6G, determined by equilibrium dialysis (8). In
this paper, we address the lack of information available for
QacR-ligand interactions by reporting on the abilities of
an impressive range of structurally diverse compounds to
induce expression of qacA transcription in the native Gram-
positive S. aureus host, since the induction of qacA expres-
sion has only previously been investigated with a limited
range of compounds (16, 25). These results are confirmed
in vitro by demonstrating the dissociation of QacR from IR1
operator DNA in the presence of inducers. A ligand-binding
assay based on intrinsic tryptophan fluorescence was also
developed to determine the relative affinities of the QacR
protein for these same ligands, which included a number of
natural plant alkaloids.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions. All cloning and
overexpression procedures performed in Escherichia coli
utilized strain DH5R (26), whereas two S. aureus strains were
employed, RN4220 (27) and the norA multidrug efflux pump
determinant knockout SAK1712 (28). Unless stated other-
wise, all strains were cultured at 37 °C in Luria-Bertani
broth or agar (26) containing, where appropriate, 100 íg
mL-1 ampicillin for E. coli and 50 íg mL-1 ethidium, 25
íg mL-1 gentamicin, 3 íg mL-1 tetracycline, or 100 íg mL-1
trimethoprim for S. aureus. E. coli was transformed by
standard procedures (26) and S. aureus by electroporation
as previously described (29), employing a pulse of 1.3 kV.
Plasmids used in this study are listed in Table 1.
DNA Manipulations. Plasmid DNA was isolated from E.
coli and S. aureus using the Quantum Prep kit (Bio-Rad)
and small-scale alkaline lysis (30), respectively. Restriction
enzymes, T4 DNA ligase, the Klenow fragment of DNA
polymerase I (all from New England Biolabs), shrimp
alkaline phosphatase (Promega), Pfu DNA polymerase
(Stratagene), and the Wizard PCR purification kit (Promega)
were each used according to the manufacturers’ instructions.
Oligonucleotides were purchased from Sigma, and automated
DNA sequencing was performed at the Australian Genome
Research Facility.
Production of a PqacA-cat Reporter Gene Fusion. A 0.8
kb PCR fragment encompassing a promoter-less pUB110 cat
gene (31), but retaining its ribosome-binding site, was
amplified from pRB394 (32) template DNA by PCR,
employing the oligonucleotide pair 5′-GACCTGCAGAAGCT-
TAGCTAGTTAAAATTTAGGAGGAATTTATATATGAC-
Table 1: Plasmids Used in This Study
plasmid description reference
pBluescript KS+ E. coli cloning vector Stratagene
pRB394 source of pUB110 cat gene 32
pSK1 S. aureus multiresistance plasmid conferring trimethoprim, gentamicin, and multidrug resistance 45
pSK412 pBR322 containing the 5.33 kb HindIII qacA-qacR encoding fragment from pSK1,
source of qacA-qacR DNA
33
pSK5201 source of rrnBT1 transcription terminator 16
pSK5676 construct for overexpression of cysteine-less QacR 17
pSK5726 SpeI-KpnI PCR clone of qacR-PqacA in pBluescript KS+ this study
pSK5728 PstI-KpnI PCR clone of pUB110 cat gene in pUC19 this study
pSK5731 pSK5728 with rrnBT1 terminator inserted downstream of cat this study
pSK5733 pSK5726 with PstI-KpnI cat-rrnBT1 fragment from pSK5731 fused to PqacA this study
pSK5743 pBluescript KS+ derivative with EcoRI and KpnI sites eliminated this study
pSK5750 5.33 kb qacA-qacR HindIII fragment from pSK412 inserted into pSK5743 this study
pSK5751 pSK5750 with EcoRI-KpnI fragment replaced with PqacA-cat-rrnBT1 fragment from pSK5733 this study
pSK5754 pSK1 containing PqacA-cat fusion introduced by homologous recombination with pSK5751 this study
pUC19 E. coli cloning vector 46
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3′ and 5′-TTAGGTACCCGGGCAGTTTATGGCGGGCGT-
CCTGC-3′ (underlined nucleotides represent inserted restric-
tion endonuclease recognition sites) and then cloned into the
PstI and KpnI sites of pUC19 to produce pSK5728. A 0.16
kb EcoRI fragment encompassing a rrnBT1 transcription
terminator was acquired from pSK5201 (16), blunt-ended,
and inserted downstream from the cat gene in pSK5728 by
way of the SmaI site previously introduced by the 3′ PCR
primer, thereby generating pSK5731 (Figure 1). To obtain a
PqacA-containing fragment suitable for fusing to the promot-
erless cat gene, the 5.33 kb HindIII qacA-qacR containing
DNA segment from pSK412 (33) was first recloned into the
HindIII site of pSK5743 (Table 1). The resultant plasmid,
pSK5750, was subsequently used as the template DNA for
a PCR reaction with the oligonucleotide pair 5′-CCG-
GAAGCTTGGGTACCAATCCTTATAGACCGTG-3′ and
5′-GAAAAAGGCGTATATATAAAGG-3′, resulting in the
generation of a 1.84 kb fragment. After cleavage of the PCR
product with SpeI and KpnI, the released 1.21 kb qacR-
PqacA fragment was cloned into the equivalent sites of
pBluescript KS+ to produce pSK5726 (Figure 1). The unique
PstI and KpnI sites, incorporated by the 3′ PCR primer, were
then utilized to insert the cat-rrnBT1 fragment from
pSK5731, thereby generating pSK5733 (Figure 1), which
contained a fusion of the cat reporter gene to PqacA. The final
product, pSK5751 (Figure 1), was created by replacement
of the pSK5750 EcoRI-KpnI fragment with that from
pSK5733. After the electroporation of pSK5751 DNA into
S. aureus strain RN4220 harboring pSK1, the pSK1 deriva-
tive pSK5754 was isolated, in which the PqacA-cat fusion
had replaced the wild-type sequences by homologous
recombination.
Chloramphenicol Acetyltransferase Assays. A stationary-
phase culture of S. aureus strain SAK1712 harboring
pSK5754 was diluted 1:100 in fresh media and grown to an
OD600 of 0.6, which equated to approximately five population
doublings and mid-log phase of growth (data not shown).
Aliquots (3 mL) were then grown for a further 1.5 h in the
presence or absence of the indicated concentrations of
potential inducing compounds and placed on ice. Cells lysis
was achieved by resuspension in 300 íL of cold buffer (10
mM EDTA, 25 mM Tris-HCl, pH 8.0) containing 0.3 mg
mL-1 lysostaphin and incubation at 37 °C for 30 min. After
centrifugation, 50 íL samples of supernatant were added to
spectrophotometer tubes containing 2900 íL of chloram-
phenicol acetyltransfersase (CAT) assay buffer, such that the
final concentrations were 100 mM Tris-HCl, pH 7.8, 0.1 mM
acetyl-CoA (Sigma), and 1 mM 5,5′-dithiobis(2-nitrobenzoic
acid) (Sigma). Reactions were equilibrated for 5 min at 37
°C, and a zero reading was obtained by measuring absor-
bance at 412 nm in a Spectronic 20 spectrophotometer at 37
°C before the addition of 0.15 mM chloramphenicol (Sigma)
followed by a second reading after a further 5 min incubation
at 37 °C. The concentration of protein in each sample
supernatant was determined with the Coomassie plus protein
assay reagent (Pierce), permitting the obtained CAT activities
to be expressed as íM Cm acetylated min-1 (mg of
protein)-1. Potential inducing compounds were obtained from
the following sources: ampicillin, benzalkonium chloride,
berberine chloride, cetylpyridinium chloride, chelerythrine
chloride, chlorhexidine diacetate, crystal violet, DAPI, de-
qualinium chloride, DiOC3, ethidium bromide, malachite
green, methyl green, palmatine chloride, proflavin, pyronin
Y, rhodamine 6G, tetracycline, and tetraphenylarsonium were
all from Sigma Aldrich, amicarbalide isethionate, phenami-
dine isethionate, and propamidine isethionate were provided
by Rhone Poulenc Rorer (Dagenham, U.K.), and the
compounds avicin and nitidine were supplied by Drs. Monroe
E. Wall and Mansukh C. Wani (Research Triangle Institute,
Research Triangle Park, NC).
Protein Purification and Gel Mobility Shift Assays. The
cysteine-less His tag derivative of QacR used throughout this
work was overexpressed from the plasmid pSK5676 and
purified by Ni2+-NTA metal chelate affinity chromatography
(Invitrogen ProBond resin) as described previously (16, 17).
Immediately following elution from the column, the QacR-
containing fractions were pooled, diluted to a concentration
not exceeding 1 mg mL-1, and dialyzed for at least 4 h at
room temperature against 4 L of buffer A [200 mM NaCl,
20 mM Tris-HCl, 5% (v/v) glycerol, pH 7.5] to remove
imidazole. After a second, overnight dialysis against fresh
buffer A, the QacR-containing solution was 0.22 ím filtered
(Millipore GS) and stored in single use aliquots at -70 °C.
Protein concentrations were determined using the Coomassie
plus protein assay reagent (Pierce), and in selected instances
their accuracy was verified by measurement of absorbance
at 205 nm in a solution of 0.01% Brij 35 (Sigma) (34). Gel
mobility shift assays, for the purposes of assessing the
activity of purified QacR preparations, and also to determine
the ability of newly identified QacR ligands to dissociate
QacR dimers from operator DNA, were performed, utilizing
a 137-bp ç-32P-labeled PqacA-IR1 operator DNA fragment
as described previously (16).
FIGURE 1: Linear map of pSK5751 insert DNA, which was subsequently recombined into pSK1 to generate the PqacA-cat fusion derivative
pSK5754. Shown is the qacR gene (black arrow), its promoter PqacR, the qacA operator DNA-binding site IR1, the fusion of the qacA
promoter (PqacA) to a cat reporter gene (dark gray arrow), the downstream rrnBT1 transcription terminator (crosshatched box), the truncated
qacA gene (white arrow), and the sin and orf112 genes (light gray arrows), which together with the majority of an IS256 insertion sequence
(light gray rectangle) are encoded by the DNA flanking the site of the reporter gene fusion. The portions of pSK5751 which are contained
by the constructs pSK5726, pSK5731, and pSK5733 are also delineated, with a bar indicating 1 kb. Restriction endonuclease sites: E,
EcoRI; H, HindIII; K, KpnI; P, PstI; S, SalI; Sm, SmaI; Sp, SpeI (those in parentheses were removed during the cloning process).
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Fluorescence Spectroscopy. Fluorescence intensity mea-
surements were made at room temperature with a Hitachi
F-4500 fluorescence spectrophotometer employing a 1 cm
 1 cm quartz cell. Tryptophan residues in QacR were
selectively excited at 295 nm, and the emission was
monitored at 340 nm with slit widths of 5 and 10 nm,
respectively. Stocks of ligands (2.5 mM) were dissolved in
DMSO and dilutions made as required in buffer B [100 mM
NaCl, 15 mM Tris-HCl, 2.5% (v/v) glycerol, pH 7.5].
Dialyzed QacR was added to buffer B at a concentration of
approximately 15 íg mL-1 (0.32 íM dimer ) [QacR]) in
an initial volume of 2 mL and titrated with increasing
amounts of each ligand by the sequential addition of 2-4
íL aliquots of the appropriate ligand stock solutions, such
that the total addition of ligand did not exceed 5% of the
initial volume. All readings were corrected for background
emission of the buffer and sample dilution. Inner filter effects
were compensated for by performing a parallel titration using
a 1 íM solution of pure tryptophan (Sigma), which produced
an initial fluorescence intensity reading approximately
equivalent to that obtained for the 15 íg mL-1 QacR samples.
The reductions in the tryptophan fluorescence intensity were
assumed to be entirely due to inner filter effects, and these
data were then used to obtain corrected fluorescence quench-
ing values (¢FC) for the titrations of QacR with ligand by
employing the equation:
where ¢FP ) the reduction in QacR fluorescence intensity
at a particular concentration of ligand, FPi ) the initial
fluorescence of QacR, ¢FW ) the reduction in tryptophan
fluorescence intensity at a particular concentration of ligand,
and FWi ) the initial fluorescence of the tryptophan solution.
Kd Determinations. The fraction of QacR dimers contain-
ing a bound ligand molecule (¢F*) was taken as the fraction
of the total quenchable tryptophan fluorescence that was
quenched at each point of the titration. To calculate ¢F*
values, the total quenchable signal was first estimated by
extrapolation at high [L] values to the Y-intercept of a plot
of 1/[L] vs 1/¢FC. For each point in a titration, the
concentration of free ligand [Lf] was also approximated by
subtracting from the total ligand concentration (in íM), [L],
the concentration of ligand molecules estimated to be bound
by QacR, ([QacR]¢F*), based on the previously determined
binding stoichiometry of one ligand molecule per QacR
dimer (8). Dissociation constants for each ligand were then
determined by using the nonlinear curve least-squares fitting
program EnzFitter (Biosoft, Cambridge, U.K.) to fit the
experimental [Lf] and ¢F* values to a single-site ligand-
binding model (eq 2), with each of the reported Kd values
representing an average from three separate Kd determina-
tions:
RESULTS
Recombination of a PqacA-cat Fusion into the pSK1
Multiresistance Plasmid. To obtain an accurate representation
of qacA induction in S. aureus, a transcriptional fusion of a
Gram-positive cat reporter gene to PqacA was generated and
the resultant construct recombined into the pSK1 multire-
sistance plasmid, the original source of the qacA-qacR locus.
Briefly, a promoter-less pUB112 cat gene was first cloned
in E. coli (pSK5728; Table 1) and then modified to include
a downstream rrnBT1 transcription terminator (pSK5731;
Table 1) in order to prevent the possible production of a
truncated QacA protein, as it has been reported that the
expression of truncated versions of other integral membrane
proteins can be deleterious to the health of bacterial cells
(35). After the fusion of the cat gene to a PqacA-IR1 sequence
with qacR in cis (pSK5733; Table 1), the quantity of pSK1
DNA flanking the cat gene was increased so as to facilitate
the planned homologous recombination event. These ma-
nipulations culminated in the production of pSK5751, in
which the PqacA-cat fusion was flanked by 2.64 and 2.52
kb of pSK1 DNA upstream and downstream of cat,
respectively (Figure 1). After electroporation of pSK5751
DNA into an S. aureus RN4220 derivative that already
harbored pSK1, recombinant plasmids were selected by
plating the cells on NYE agar (29) containing 25 íg mL-1
gentamicin and 100 íg mL-1 trimethoprim to select for
pSK1, in addition to 5 íg mL-1 chloramphenicol and a
subminimum inhibitory concentration (10 íg mL-1) of
proflavin, a compound previously shown to cause induction
of transcription from PqacA (16). Because pSK5751 lacked
S. aureus replication functions, the obtained chlorampheni-
col-resistant colonies should be the product of the desired
recombination event. Indeed, this appeared to be the case,
as each isolate possessed a plasmid marginally larger in size
than pSK1, as would be expected for the additional 0.82 kb
of DNA that resulted from the insertion of the cat gene and
concomitant deletion of the first 157 bp of the qacA gene.
One of these pSK1 derivatives containing a PqacA-cat fusion
was designated pSK5754. Verification of a successful
recombination event that disrupted the qacA gene was
provided by the growth of RN4220 harboring pSK1, but not
the equivalent strain containing pSK5754, in the presence
of 100 íg mL-1 ethidium or 100 íg mL-1 proflavin,
compounds which are substrates of the QacA MDR pump
(22). The integrity of the DNA surrounding the fusion site
was validated by PCR, with the appropriately sized fragment
being obtained in each case, in addition to the verification
of the DNA sequence for the segment that encompassed
qacR, the intergenic region, and the cat gene (data not
shown).
Induction of qacA Expression in S. aureus. The S. aureus
chromosomally encoded NorA MDR pump shares a number
of common substrates with the QacA MDR transporter, such
as tetraphenylarsonium, benzalkonium, rhodamine 6G, and
ethidium (22, 36, 37). To avoid expression of NorA from
potentially masking the ability of some compounds to act
as inducers of qacA transcription, the S. aureus strain
SAK1712 (28) was employed, in which the norA coding
region has been disrupted by the insertion of the pT181-
derived TetA(K) tetracycline resistance cassette. The high
specificity of the pT181-encoded efflux protein for only
tetracycline and some closely related analogues (38) pre-
cluded any influence on the intracellular concentrations of
the compounds analyzed in this study. After transformation
of strain SAK1712 with pSK5754, a resultant transformant
¢FC )
¢FP - FPi(¢FW/FWi)
FPi
(1)
¢F* ) ¢F*max
[Lf]
[Lf] - Kd
(2)
Induction and Binding Affinities of QacR Ligands Biochemistry, Vol. 42, No. 51, 2003 15229
was employed for CAT assays to determine the ability of
structurally diverse compounds to act as inducers of qacA
transcription. The potential QacR ligands assessed included
a number of recently identified monovalent and bivalent
QacA substrates (23) and a range of natural plant alkaloids
which share some structural similarities with known synthetic
QacR ligands (Figure 2).
Initially, as a control, the S. aureus strain SAK1712
harboring pSK1 was used in CAT assays; no CAT activity
was detectable, a result which did not change upon the
FIGURE 2: Chemical structures of QacR ligands. Depicted are the monovalent Qacs tetraphenylarsonium, cetylpyridinium, and benzalkonium
(R1 ) C12H25, C14H29, or C16H33), the bivalent Qac dequalinium, the monovalent dyes rhodamine 6G, crystal violet [R2 ) N(CH3)2], malachite
green (R2 ) H), ethidium, DiOC3, pyronin Y, and proflavin, the bivalent dye methyl green, the bivalent guanidine chlorhexidine, the bivalent
diamidines amicarbalide, DAPI, phenamidine, and propamidine, and the plant alkaloids palmatine, berberine, nitidine (R3 ) OCH3, R4 )
H), chelerythrine (R3 ) H, R4 ) OCH3), and avicin.
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addition of known QacR ligands (data not shown). In
comparison, even in the absence of inducing compounds, a
significant basal level of CAT activity was detected for
SAK1712 harboring pSK5754 (Figure 3). More importantly,
upon addition of many of the potential QacR ligands,
substantial increases in transcription from PqacA were observed
(Figure 3), the maximal levels of which were classified either
as a low (less than 2-fold), moderate (2-3-fold), or strong
(greater than 3-fold) increase in the basal expression (Table
2). For example, addition of increasing amounts of the strong
inducer methyl green, a bivalent dye, resulted in a gradual
increase in the detected CAT activity, from a basal level of
125 units to a maximum of 398 units at 31 íM methyl green
(Figure 3B and Table 2). Other compounds classified as
strong inducers were the monovalent dyes rhodamine 6G
and DiOC3 (Figure 3B), the monovalent quaternary am-
monium compound (Qac) tetraphenylarsonium, the bivalent
Qac dequalinium (Figure 3D), and the plant alkaloid ber-
berine (Figure 3C). The monovalent Qac benzalkonium
(Figure 3D), the monovalent dye crystal violet (Figure 3B),
and the plant alkaloids nitidine and palmatine (Figure 3C)
were all moderate inducers of PqacA expression. Weak
inducers of PqacA expression included the monovalent dyes
proflavin, pyronin Y, and ethidium (Figure 3A), the bivalent
guanidine chlorhexidine (Figure 3E), and the bivalent dia-
midine DAPI (Figure 3E). The sharp drop-off in CAT
activity seen with many compounds at higher concentrations
is explained by the inhibitory effect on cell growth that was
observed at these high levels of inducer (data not shown).
The inducing status of the monovalent dye malachite green
(Figure 3B and Table 2), the plant alkaloids chelerythrine
(Figure 3C) and avicin (Table 2), the Qac cetylpyridinium
(Figure 3D), and the diamidines amicarbalide, propamidine,
and phenamidine (Figure 3E and Table 2) was unclear, as
after an initial drop in CAT activity, they each only caused
a small increase in transcription from PqacA, such that it did
not substantially exceed the value obtained in the absence
of any inducing compound. The addition of ampicillin and
tetracycline, representing control antimicrobials which are
not QacA substrates, failed to cause an increase in qacA
expression (data not shown).
Gel Mobility Shift. To confirm that the observed increases
in qacA expression represented a direct interaction with
QacR, the ability of compounds to dissociate purified QacR
protein from IR1-containing DNA was assessed by gel
mobility shift analysis for all of the newly identified inducers.
All compounds which had a significant effect on PqacA
transcription in vivo were found to also inhibit binding of
QacR to PqacA-IR1 containing probe DNA in vitro (Figure
4). Interestingly, one of the weakest inducers, pyronin Y,
had a significant in vitro effect at less than 100 íM (Figure
4A), requiring a lower concentration than the strongest
inducer, DiOC3 (Figure 3B), to completely dissociate QacR
from IR1. Similarly, although the maximal induction by
methyl green occurred at a concentration 6-fold greater than
that required for DiOC3 (Table 2), the former compound
completely dissociated QacR from operator DNA at a much
lower concentration than the latter (Figure 4A). Because
excess concentrations of the control noninducing antimicro-
bials ampicillin, tetracycline, and chloramphenicol did not
dissociate QacR from IR1 DNA (Figure 4B), it indicated
that the effects observed upon addition of the plant alkaloids
chelerythrine and avicin, as well as the diamidines amicar-
balide, phenamidine, and propamidine (Figure 4), represented
a real interaction with QacR, despite these compounds only
inducing poorly or not at all in vivo (Figure 3).
Ligand-Binding Assay: Intrinsic Tryptophan Fluores-
cence. QacR contains three highly fluorescent tryptophan
residues, one of which is known to directly participate in
ligand binding (8). Therefore, it appeared probable that an
assay based on the intrinsic fluorescence of QacR could be
developed to measure the relative binding affinities of QacR
for different ligands. Although QacR possesses two ligand-
binding pockets per dimer, the structural information avail-
able for six different ligands indicated that, in each case,
binding of the ligand to one site caused nearly identical
structural changes, which sterically hindered access of ligands
to the second site (8). For the compound rhodamine 6G, a
binding stoichiometry of one molecule per QacR dimer had
been confirmed by equilibrium dialysis (8). Thus, the
fluorescence quenching data obtained from titration of QacR
with ligands were fitted to a single-site ligand-binding model.
Initial experiments revealed that the tryptophan fluores-
cence of QacR could be readily quenched by the addition of
submicromolar to low micromolar concentrations of rhodamine
6G in a concentration-dependent manner (Figure 5A),
whereas the same concentrations of rhodamine 6G had little
effect on the fluorescence of a solution of pure tryptophan
(Figure 5A). Fitting of the corrected [Lf] and ¢F* values to
a single-site binding model produced an excellent fit (Figure
5B), generating a dissociation constant (Kd) of 197 ( 15
nM, which is in good agreement with the value of 101 ( 4
nM previously determined for rhodamine 6G by equilibrium
dialysis (8).
The binding assay was successfully employed to determine
Kd values for the majority of compounds known to cause
induction of qacA expression in vivo (Figure 3) and/or
dissociation of QacR from IR1 operator DNA in vitro (Figure
4) (16). Unfortunately, dequalinium and propamidine both
exhibited significant fluorescence at 340 nm, and addition
of benzalkonium caused a slight increase of QacR fluores-
cence; QacR binding of these compounds could not be
studied with this method. The results of Kd determinations
for the 14 monovalent and 5 bivalent compounds are
presented in Table 2. The two compounds which were clearly
bound the strongest by QacR, crystal violet and rhodamine
6G, are both monovalent dyes, although their chemical
structures are rather disparate (Figure 2). The other five
monovalent dyes and the Qac cetylpyridinium were also
bound relatively strongly by QacR (Table 2), whereas the
bivalent dye methyl green had a significantly higher Kd of
7.04 ( 2.69 íM. In fact, with the exception of DAPI, all of
the bivalent compounds had relatively high Kd values,
irrespective of the class of the compound; tetraphenylarso-
nium was the only monovalent compound found to be bound
more weakly (Table 2). The five plant alkaloids tested
exhibited similar Kd values to each other, from a low of 2.63
( 0.13 íM for avicin to a high of 4.89 ( 0.83 íM for
nitidine (Table 2). However, it should be noted that only
approximate values could be obtained for the plant alkaloids
berberine and palmatine, due to the severity of the inner filter
effects for these compounds, such that a marked reduction
in the fluorescence of free tryptophan was observed.
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FIGURE 3: Induction of transcription from the PqacA-cat fusion in pSK5754 following the addition of potential QacR ligands, determined
in the S. aureus norA knockout strain SAK1712. (A) Monovalent dyes proflavin (filled diamonds), pyronin Y (open circles), and ethidium
(filled squares). (B) Monovalent dyes crystal violet (filled triangles), malachite green (filled diamonds), rhodamine 6G (open circles), and
DiOC3 (open squares) and the bivalent dye methyl green (open triangles). (C) Monovalent plant alkaloids berberine (filled squares), palmatine
(filled triangles), nitidine (filled diamonds), and chelerythrine (open circles). (D) Bivalent Qac dequalinium (open squares) and the monovalent
Qacs tetraphenylarsonium (filled circles), benzalkonium (filled triangles), and cetylpyridinium (open circles). (E) Bivalent guanidine
chlorhexidine (open squares) and the bivalent diamidines DAPI (filled diamonds), amicarbalide (filled circles), and propamidine (open
triangles).
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DISCUSSION
This paper proffers the first detailed study of the range of
compounds bound by the multiligand-binding repressor
QacR. Application of the PqacA-cat reporter gene fusion
provided an accurate picture of induction from the qacA
promoter when both PqacA and the divergently transcribed
qacR gene were present in their natural location in the pSK1
multiresistance plasmid (Figure 3) and expressed in the native
staphylococcal host. Variance from data previously obtained
using an E. coli promoter-probe vector (16) may well be
attributable to the outer membrane of Gram-negative organ-
isms, which provides E. coli with an added barrier to the
entry of antimicrobial compounds. Additionally, the employ-
ment of an S. aureus norA knockout mutant may also have
increased the sensitivity of the qacA induction assays. For
example, the bivalent biguanidine chlorhexidine, which had
previously been classified as noninducing and represents a
chemical class distinct from that of other inducers (Figure
2), has now been unambiguously reclassified as an inducing
compound. Chlorhexidine was observed to cause a low but
significant increase in the level of PqacA transcription (Table
2; 1.8-fold), a result which was supported by the ability of
chlorhexidine to dissociate QacR from IR1 DNA in vitro
(16) and the determination of a Kd value of 11.42 ( 0.63
íM (Table 2). In a similar fashion, what appeared to be a
low level of induction by the Qac cetylpyridinium (Table 2;
1.2-fold) was also matched by the ability of this compound
to both bind QacR in vitro (Table 2; Kd of 0.47 ( 0.05 íM)
and dissociate it from IR1 DNA (16). Compounds that were
capable of mediating 1.6- and 3.5-fold increases in qacA
transcription, respectively, also included the newly identified
inducers pyronin Y and DiOC3, both of which are mono-
valent dyes that had Kd values in the low micromolar range
(Table 2).
The bivalent dye methyl green is highly similar in structure
to the monovalent compounds crystal violet and malachite
green (Figure 2) and represents the first example of a QacR
ligand that is not itself a substrate of the QacA transporter
(B. A. Mitchell, M. H. Brown, and R. A. Skurray, unpub-
lished data). Induction by methyl green required relatively
high concentrations (Figure 3B and Table 2), in line with
the higher Kd value obtained for this compound (Table 2;
7.04 ( 2.69 íM). However, in comparison to these methyl
green results, the Kd values in general did not correlate very
well with the strength of in vivo induction. For example,
the newly identified inducer tetraphenylarsonium had the
highest Kd (Table 2; 81.78 ( 11.27 íM) and required a
substantial concentration to disrupt QacR-IR1 complexes
(Figure 4B) but exhibited strong in vivo induction (Table 2;
3.4-fold). In contrast, cetylpyridinium only induced very
Table 2: Ligand-Binding Affinities of QacR and Maximum Fold in
Vivo Induction
maximum
in vivo inductionb
compound
binding affinity
(íM) (Kd)a
x-fold
increase
concn
(íM)
dyes
crystal violet 0.3 ( 0.02 2.4 0.05
DiOC3c 1.77 ( 0.22 3.5 5.2
ethidium 0.81 ( 0.24 1.5 49
malachite green 1.76 ( 1.05 1.1 1.0
methyl greenc 7.04 ( 2.69 3.2 31
proflavin 3.15 ( 0.639 1.4 4.6
pyronin Y 5.15 ( 0.47 1.6 10
rhodamine 6G 0.20 ( 0.02 4.1 0.52
quaternary ammonium
compounds
benzalkonium ndd 2.6 4.7
cetylpyridinium 0.47 ( 0.05 1.2 0.05
dequaliniumc ndd 3.3 1.2
tetraphenylarsonium 81.78 ( 11.27 3.4 2.4
guanidines
chlorhexidinec 11.42 ( 0.63 1.8 3.2
diamidines
amicarbalidec 16.21 ( 0.53 1.2 0.14
DAPIc 1.12 ( 0.18 1.9 0.36
phenamidinec 9.21 ( 0.35 0.93 1.9
propamidinec ndd 0.83 0.35
plant alkaloids
avicin 2.63 ( 0.13 1.1 10
berberinee 2.88 ( 0.52 3.1 86
chelerythrine 4.08 ( 1.07 1.1 3.9
nitidine 4.89 ( 0.83 2.2 160
palmatinee 3.74 ( 0.67 2.7 170
a Values are an average from three separate experiments. b Values
represent the maximum level of CAT activity observed in the presence
of each compound such that a value of 1 represents the level of
transcription originating from PqacA in the absence of any inducing
compound. Also recorded is the corresponding optimum concentration
for each compound (Figure 3 and data not shown). c Bivalent com-
pounds. d Not determined (see text). e Due to the severity of the inner
filter effect, only approximate Kd values could be determined for
berberine and palmatine.
FIGURE 4: Gel mobility shift assays demonstrating dissociation of
QacR from IR1 operator DNA in vitro following the addition of
QacR ligands. 500 cpm of a 32P-labeled 137-bp PqacA-IR1 containing
fragment (a) was incubated in the presence (+) or absence (-) of
0.4 ng of purified QacR and in some cases with the addition of the
indicated concentrations (in íM) of potential QacR ligands.
Formation of a QacR-IR1 DNA complex (b) retarded the degree
to which the probe DNA migrated into the gel. QacR ligands are
abbreviated as follows: Amc, amicarbalide; Ap, ampicillin; Avc,
avicin; Brb, berberine; Chr, chlorhexidine; Cm, chloramphenicol;
MaG, malachite green; MeG, methyl green; Ntd, nitidine; Phn,
phenamidine; Pi, propamidine; Plm, palmatine; PyY, pyronin Y;
Tc, tetracycline; TPA, tetraphenylarsonium
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poorly (Figure 3D and Table 2; 1.2-fold), despite a demon-
stration of strong in vitro binding (Table 2; Kd of 0.47 (
0.05 íM) (16). A range of bivalent diamidines, including
the structurally distinct compound DAPI, were also identified
as ligands of QacR (Figures 3E and 4A). DAPI bound
significantly more tightly to QacR than the other bivalent
compounds (Table 2; Kd of 1.12 ( 0.18 íM), suggesting a
more precise fit of this compound in the extended QacR
ligand-binding pocket. The limited level of induction ob-
served for the other diamidines, viz., amicarbalide, phen-
amidine, and propamidine, ranging from 0.83-fold to 1.2-
fold (Table 2), may reflect the concentrations that were
required to observe an in vitro effect on DNA binding (Figure
4) vastly exceeding the maximum concentration at which
they could be employed in vivo (Figure 3). In addition to
toxicity, there are several other explanations which can
account for a failure to observe significant in vivo induction
for a compound that can readily dissociate QacR from IR1
DNA in vitro. For example, the ability of a given ligand to
enhance qacA transcription is related not only to how strongly
it is bound by QacR but also to the relative affinity of the
compound for its target site, the ease with which it gains
entry into the cytoplasm, and the presence of MDR trans-
porter homologues which may export the compound in
question, thereby reducing its intracellular concentration. For
the specific case of ethidium, proflavin, and pyronin Y, the
discrepancy between their relatively low Kd values, ranging
from 0.81 to 5.15 íM, but only weak induction of PqacA in
vivo (Table 2) may be related to the ability of these
compounds to intercalate DNA (39). This property could
result in a reduction in the effective intracellular concentra-
tions of such QacR ligands due to their nonspecific seques-
tration in chromosomal DNA. Although DNA intercalation
could also enhance the effect of these compounds in gel
mobility shift experiments, it does not influence the finding
that QacR has a strong affinity for these ligands, as
determined by the intrinsic tryptophan fluorescence assay
(Table 2).
Taking into account the data presented here, the number
of bivalent compounds that QacR is known to be capable of
binding has now increased from a sole example, dequalinium,
to seven, which in combination with the additional mono-
valent ligands that were identified indicates that the range
of compounds bound by QacR is substantially greater than
previously thought. This finding is particularly interesting
in light of the fact that QacR also regulates the expression
of QacB, a closely related protein from which QacA appears
to have recently evolved via the acquisition of a high-affinity
binding site for bivalent substrates (20, 22, 40). Importantly,
although all of the known bivalent ligands of QacR, with
the exception of methyl green, are also substrates of QacA,
these same bivalent compounds are very poor substrates of
QacB. Thus, it appears likely that the QacR regulator
possessed bivalent cation-binding ability prior to the acquisi-
tion by QacA of a high-affinity bivalent substrate-binding
site. Furthermore, an inability to induce qacA transcription
does not mean that a compound should be disregarded as an
important QacA substrate, as a significant degree of QacA-
mediated resistance to a noninducing compound, such as
phenamidine (23), can still occur in the absence of induction.
This situation arises from the finding that although the qacA
promoter drives relatively strong transcription in S. aureus
(41), full repression by QacR only results in a 6-fold decrease
in promoter activity (41). The significant basal level of
transcription from uninduced PqacA was also clearly demon-
strated by the PqacA-cat fusion generated in this study (Figure
3).
This study also clearly demonstrated for the first time in
vivo induction of a bacterial MDR determinant by the natural
plant antimicrobials berberine, palmatine, and nitidine (Figure
3C). QacR was confirmed to bind these plant alkaloids and
the additional compounds, chelerythrine and avicin, in vitro
(Figure 4), with Kd values in the low micromolar range
(Table 2). In comparison, all other QacR ligands which have
FIGURE 5: Binding of the ligand rhodamine 6G to QacR determined
by quenching of intrinsic tryptophan fluorescence. (A) Fluorescence
quenching of QacR (diamonds) and free tryptophan (squares) by
the addition of increasing amounts of rhodamine 6G, with ìex set
at 295 nm and ìem at 340 nm. (B) Determination of the dissociation
constant (Kd) for rhodamine 6G. At each point in the titration shown
in (A), the QacR fluorescence values were corrected for inner filter
effects using eq 1 in the Experimental Procedures, and the free
rhodamine 6G concentration was adjusted for the estimated quantity
of ligand bound by QacR. The proportion of the quenchable QacR
fluorescence signal (¢F*) quenched at each step in the titration
and the corresponding values for the free ligand concentrations
[R6Gfree] were then fitted to eq 2 of the Experimental Procedures.
The points represent the data derived from (A), with the line
representing the best fit of these data to eq 2, in this instance
generating a Kd value for rhodamine 6G of 198 nM.
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been identified to date are artificial substances that have only
recently been synthesized. This situation is at odds with the
widespread distribution of MDR transporters (42), which
suggests that these transporters are likely to have important
physiological functions related to the export of unidentified
substrates encountered in the normal environment of each
organism. Although the ability of QacA to efflux palmatine,
nitidine, avicin, and chelerythrine has yet to be investigated,
at the very least, berberine is likely to represent a natural
MDR substrate, as this plant alkaloid is a substrate of both
the plasmid-encoded QacA and also the chromosomally
encoded NorA S. aureus MDR pumps (10-12). Taken
together, these findings are suggestive of a preexisting role
for the QacA-QacR system in providing resistance to plant
and other naturally occurring, cationic and hydrophobic,
antimicrobial compounds. Thus, to provide resistance against
antiseptics and disinfectants prevalent in the hospital envi-
ronment, S. aureus appears to employ a system that may
have evolved for the export of natural compounds which
share broad chemical and structural similarities with many
synthetic MDR transporter substrates (Figure 2). The high-
affinity binding of both the QacA transporter and also the
QacR regulator to the same range of compounds also
suggests that these synthetic substances closely resemble the
intended physiological function of the qacA-qacR locus. In
contrast, unlike QacR, most MDR regulatory systems fail
to increase the synthesis of their target genes in response to
the known substrates of their cognate MDR transporters (7).
The versatile nature of the extended QacR ligand-binding
pocket (8) is made more remarkable by the fact that
structurally diverse compounds bind with submicromolar Kd
values to each of the linked sites that make up the extended
pocket: ethidium near the surface with a Kd of 0.81 ( 0.24
íM, rhodamine 6G in the more internal position with a Kd
of 0.20 ( 0.02 íM, and the less-planar crystal violet in an
intermediate location with a Kd of 0.3 ( 0.02 íM. Moreover,
it is interesting to note that the Kd values determined for a
number of QacR ligands were significantly lower than that
of the most strongly bound ligand of the BmrR multidrug-
binding protein (43). This suggests that the shared ability of
these proteins to bind MDR substrates may be a closer match
to the intended physiological function of QacR than it is to
the natural function of BmrR. In summary, this study has
provided additional evidence to support the notion that the
primary function of the qacA-qacR system is to provide a
general protection system against cationic and lipophilic toxic
compounds, which includes a number of currently utilized
antimicrobials, such as benzalkonium and chlorhexidine,
antimicrobials that were historically employed as antiseptics,
for example proflavin, and a range of natural plant anti-
microbials. The lack of any clear-cut relationship between
the structure of a QacR ligand and its Kd value indicates
that the extended binding pocket has evolved to accom-
modate the broadest possible range of toxic hydrophobic
cations, rather than a specific class of chemicals, endorsing
a proposal that at least some MDR exporters function as
general removal systems for hydrophobic molecules (44).
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